Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells (2024)
- Authors:
- USP affiliated authors: MACHADO NETO, JOÃO AGOSTINHO - ICB ; CARVALHO, MARIA FERNANDA LOPES - ICB ; ALMEIDA, BRUNA OLIVEIRA DE - ICB ; MIRANDA, LÍVIA MARIA BETTINI DE - EESC ; SILVA, JEAN CARLOS LIPRERI DA - ICB ; LIMA, KELI CRISTINA DE - FM
- Unidades: ICB; EESC; FM
- DOI: 10.1016/j.clinsp.2024.100422
- Subjects: FARMACOLOGIA; CÉLULAS CULTIVADAS DE TUMOR; ADENOCARCINOMA; ANTINEOPLÁSICOS; CARCINOMA DE CÉLULAS ESCAMOSAS; NEOPLASIAS DO SISTEMA DIGESTÓRIO; NEOPLASIAS UTERINAS; RNA MENSAGEIRO; EXPRESSÃO GÊNICA; REGULAÇÃO GÊNICA; PROLIFERAÇÃO CELULAR
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: São Paulo, SP
- Date published: 2024
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
CARVALHO, Maria Fernanda Lopes et al. Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells. Clinics, v. 79, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.clinsp.2024.100422. Acesso em: 27 dez. 2025. -
APA
Carvalho, M. F. L., Calicchio, C. S., Almeida, B. O. de, Miranda, L. B. L. D., Silva, J. C. L. da, Lima, K., & Machado Neto, J. A. (2024). Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells. Clinics, 79. doi:10.1016/j.clinsp.2024.100422 -
NLM
Carvalho MFL, Calicchio CS, Almeida BO de, Miranda LBLD, Silva JCL da, Lima K, Machado Neto JA. Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells [Internet]. Clinics. 2024 ; 79[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.clinsp.2024.100422 -
Vancouver
Carvalho MFL, Calicchio CS, Almeida BO de, Miranda LBLD, Silva JCL da, Lima K, Machado Neto JA. Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells [Internet]. Clinics. 2024 ; 79[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.clinsp.2024.100422 - Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes
- Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents
- NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells
- Synthesis and evaluation of 2-substituted quinazolin-4(3H)-ones as potential antileukemic agents
- Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
- Exploring redox vulnerabilities in JAK2V617F-positive cellular models
- miRNAs as prognostic predictors in acute myeloid leukemia [Editorial]
- ANKHD1 contributes to the malignant phenotype of triple-negative breast cancer cells
- Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia
- ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia
Informações sobre o DOI: 10.1016/j.clinsp.2024.100422 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
